Click for best price
Amyotrophic Lateral Sclerosis Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 308.7 million
|
Forecast Market size by 2029 |
US$ 359.5 million
|
| Growth Rate |
CAGR of 2.2% |
Number of Pages |
60 Pages |
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig?s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5?10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
This report aims to provide a comprehensive presentation of the global market for Amyotrophic Lateral Sclerosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyotrophic Lateral Sclerosis Drugs. This report contains market size and forecasts of Amyotrophic Lateral Sclerosis Drugs in global, including the following market information:
Global Amyotrophic Lateral Sclerosis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Amyotrophic Lateral Sclerosis Drugs market was valued at US$ 308.7 million in 2022 and is projected to reach US$ 359.5 million by 2029, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
GlobalAmyotrophic Lateral Sclerosis (ALS) Treatment key players include Mitsubishi Tanabe Pharma, Sanofi, etc. Global top two manufacturers hold a share over 80%.
North America is the largest market, with a share about 60%, followed by Japan, and Europe, both have a share over 20 percent.
In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%. And in terms of application, the largest application is Hospital, followed by Drugs Store, etc.
We surveyed the Amyotrophic Lateral Sclerosis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amyotrophic Lateral Sclerosis Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Amyotrophic Lateral Sclerosis Drugs Market Segment Percentages, by Type, 2022 (%)
Riluzole
Edaravone (Radicava)
CoQ10
Butylphthalide
Others
Global Amyotrophic Lateral Sclerosis Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Amyotrophic Lateral Sclerosis Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Amyotrophic Lateral Sclerosis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Amyotrophic Lateral Sclerosis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Amyotrophic Lateral Sclerosis Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Amyotrophic Lateral Sclerosis Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Mitsubishi Tanabe Pharma
Mylan
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
Ascend Laboratories
EISAI
Outline of Major Chapters:
Chapter 1: Introduces the definition of Amyotrophic Lateral Sclerosis Drugs, market overview.
Chapter 2: Global Amyotrophic Lateral Sclerosis Drugs market size in revenue.
Chapter 3: Detailed analysis of Amyotrophic Lateral Sclerosis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amyotrophic Lateral Sclerosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Amyotrophic Lateral Sclerosis Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 308.7 million
|
| Forecast Market size by 2029 |
US$ 359.5 million
|
| Growth Rate |
CAGR of 2.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Amyotrophic Lateral Sclerosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amyotrophic Lateral Sclerosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Amyotrophic Lateral Sclerosis Drugs Overall Market Size
2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size: 2022 VS 2029
2.2 Global Amyotrophic Lateral Sclerosis Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Amyotrophic Lateral Sclerosis Drugs Players in Global Market
3.2 Top Global Amyotrophic Lateral Sclerosis Drugs Companies Ranked by Revenue
3.3 Global Amyotrophic Lateral Sclerosis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Amyotrophic Lateral Sclerosis Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Amyotrophic Lateral Sclerosis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Amyotrophic Lateral Sclerosis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Amyotrophic Lateral Sclerosis Drugs Market Size Markets, 2022 & 2029
4.1.2 Riluzole
4.1.3 Edaravone (Radicava)
4.1.4 CoQ10
4.1.5 Butylphthalide
4.1.6 Others
4.2 By Type - Global Amyotrophic Lateral Sclerosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Amyotrophic Lateral Sclerosis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Amyotrophic Lateral Sclerosis Drugs Revenue, 2024-2029
4.2.3 By Type - Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Amyotrophic Lateral Sclerosis Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Amyotrophic Lateral Sclerosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Amyotrophic Lateral Sclerosis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Amyotrophic Lateral Sclerosis Drugs Revenue, 2024-2029
5.2.3 By Application - Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Amyotrophic Lateral Sclerosis Drugs Market Size, 2022 & 2029
6.2 By Region - Global Amyotrophic Lateral Sclerosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Amyotrophic Lateral Sclerosis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Amyotrophic Lateral Sclerosis Drugs Revenue, 2024-2029
6.2.3 By Region - Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Amyotrophic Lateral Sclerosis Drugs Revenue, 2018-2029
6.3.2 US Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.3.3 Canada Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.3.4 Mexico Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Amyotrophic Lateral Sclerosis Drugs Revenue, 2018-2029
6.4.2 Germany Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.4.3 France Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.4.4 U.K. Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.4.5 Italy Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.4.6 Russia Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.4.8 Benelux Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Amyotrophic Lateral Sclerosis Drugs Revenue, 2018-2029
6.5.2 China Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.5.3 Japan Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.5.4 South Korea Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.5.6 India Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Amyotrophic Lateral Sclerosis Drugs Revenue, 2018-2029
6.6.2 Brazil Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.6.3 Argentina Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Revenue, 2018-2029
6.7.2 Turkey Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.7.3 Israel Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
6.7.5 UAE Amyotrophic Lateral Sclerosis Drugs Market Size, 2018-2029
7 Amyotrophic Lateral Sclerosis Drugs Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.1.4 Sanofi Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Mitsubishi Tanabe Pharma
7.2.1 Mitsubishi Tanabe Pharma Company Summary
7.2.2 Mitsubishi Tanabe Pharma Business Overview
7.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.2.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.2.5 Mitsubishi Tanabe Pharma Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.3.4 Mylan Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 Apotex
7.4.1 Apotex Company Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.4.4 Apotex Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.4.5 Apotex Key News & Latest Developments
7.5 Glemark Generics
7.5.1 Glemark Generics Company Summary
7.5.2 Glemark Generics Business Overview
7.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.5.4 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.5.5 Glemark Generics Key News & Latest Developments
7.6 Sun Pharma
7.6.1 Sun Pharma Company Summary
7.6.2 Sun Pharma Business Overview
7.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.6.4 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.6.5 Sun Pharma Key News & Latest Developments
7.7 Covis Pharma
7.7.1 Covis Pharma Company Summary
7.7.2 Covis Pharma Business Overview
7.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.7.4 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.7.5 Covis Pharma Key News & Latest Developments
7.8 Lunan Pharma
7.8.1 Lunan Pharma Company Summary
7.8.2 Lunan Pharma Business Overview
7.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.8.5 Lunan Pharma Key News & Latest Developments
7.9 CSPC Pharmaceutical
7.9.1 CSPC Pharmaceutical Company Summary
7.9.2 CSPC Pharmaceutical Business Overview
7.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.9.4 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.9.5 CSPC Pharmaceutical Key News & Latest Developments
7.10 Ascend Laboratories
7.10.1 Ascend Laboratories Company Summary
7.10.2 Ascend Laboratories Business Overview
7.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.10.4 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.10.5 Ascend Laboratories Key News & Latest Developments
7.11 EISAI
7.11.1 EISAI Company Summary
7.11.2 EISAI Business Overview
7.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Major Product Offerings
7.11.4 EISAI Amyotrophic Lateral Sclerosis Drugs Revenue in Global Market (2018-2023)
7.11.5 EISAI Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Amyotrophic Lateral Sclerosis Drugs Market Opportunities & Trends in Global Market
Table 2. Amyotrophic Lateral Sclerosis Drugs Market Drivers in Global Market
Table 3. Amyotrophic Lateral Sclerosis Drugs Market Restraints in Global Market
Table 4. Key Players of Amyotrophic Lateral Sclerosis Drugs in Global Market
Table 5. Top Amyotrophic Lateral Sclerosis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Amyotrophic Lateral Sclerosis Drugs Product Type
Table 9. List of Global Tier 1 Amyotrophic Lateral Sclerosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Amyotrophic Lateral Sclerosis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Amyotrophic Lateral Sclerosis Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Amyotrophic Lateral Sclerosis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Amyotrophic Lateral Sclerosis Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Sanofi Company Summary
Table 31. Sanofi Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 32. Sanofi Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Mitsubishi Tanabe Pharma Company Summary
Table 35. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 36. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Mitsubishi Tanabe Pharma Key News & Latest Developments
Table 38. Mylan Company Summary
Table 39. Mylan Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 40. Mylan Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Mylan Key News & Latest Developments
Table 42. Apotex Company Summary
Table 43. Apotex Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 44. Apotex Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Apotex Key News & Latest Developments
Table 46. Glemark Generics Company Summary
Table 47. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 48. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Glemark Generics Key News & Latest Developments
Table 50. Sun Pharma Company Summary
Table 51. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 52. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Sun Pharma Key News & Latest Developments
Table 54. Covis Pharma Company Summary
Table 55. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 56. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Covis Pharma Key News & Latest Developments
Table 58. Lunan Pharma Company Summary
Table 59. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 60. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Lunan Pharma Key News & Latest Developments
Table 62. CSPC Pharmaceutical Company Summary
Table 63. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 64. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. CSPC Pharmaceutical Key News & Latest Developments
Table 66. Ascend Laboratories Company Summary
Table 67. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 68. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Ascend Laboratories Key News & Latest Developments
Table 70. EISAI Company Summary
Table 71. EISAI Amyotrophic Lateral Sclerosis Drugs Product Offerings
Table 72. EISAI Amyotrophic Lateral Sclerosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. EISAI Key News & Latest Developments
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis Drugs Segment by Type in 2022
Figure 2. Amyotrophic Lateral Sclerosis Drugs Segment by Application in 2022
Figure 3. Global Amyotrophic Lateral Sclerosis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Amyotrophic Lateral Sclerosis Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Amyotrophic Lateral Sclerosis Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue in 2022
Figure 8. By Type - Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 16. US Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 28. China Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Amyotrophic Lateral Sclerosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Sanofi Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mylan Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Apotex Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. EISAI Amyotrophic Lateral Sclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
